{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T13:47:17Z","timestamp":1705585637123},"reference-count":19,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[1999,10,1]]},"abstract":"<jats:p> We investigated the pharmacokinetics of recombinant human insulin-like growth factor I (rhIGF-I) in growth hormone deficiency (GHD). Nine GHD adults [age 25 \u00b1 3 (SE) yr] received rhIGF-I (60 \u03bcg\/kg sc) twice, 10 h apart, and blood was sampled over 24 h. IGF-I and free IGF-I concentrations increased, whereas IGF binding protein 3 (IGFBP-3) and acid labile subunit (ALS) were unchanged during treatment. There was no correlation between absorption or terminal half-life of IGF-I and IGFBP-3 or ALS, but negative correlations with IGF-I clearance (CL\/F) and volume of distribution (V\/F). Positive correlations between both IGFBP-3 and ALS and IGF-I maximal concentration (C<jats:sub>max<\/jats:sub>) and time of C<jats:sub>max<\/jats:sub>( T <jats:sub>max<\/jats:sub>) were observed. Compared with normal individuals studied similarly (using 80 \u03bcg\/kg), GHD subjects showed a normal absorption half-life, a faster elimination half-life, lower C<jats:sub>max<\/jats:sub>, yet normal T <jats:sub>max<\/jats:sub>and V\/F. In conclusion, GHD is associated with normal absorption and distribution of IGF-I yet faster elimination kinetics. Additionally, IGFBP-3 and ALS concentrations modulate the peak concentrations of IGF-I achieved and correlate reciprocally with its V\/F and CL\/F, underscoring the critical importance of binding proteins in modulating the bioavailability of IGF-I in vivo in humans. <\/jats:p>","DOI":"10.1152\/ajpendo.1999.277.4.e579","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T07:01:47Z","timestamp":1513926107000},"page":"E579-E584","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics of insulin-like growth factor I  in hypopituitarism: correlation with binding proteins"],"prefix":"10.1152","volume":"277","author":[{"given":"Nelly","family":"Mauras","sequence":"first","affiliation":[{"name":"Nemours Children\u2019s Clinic, Jacksonville, Florida 32207; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Quarmby","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California 94080"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane C.","family":"Bloedow","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California 94080"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1651-2227.1993.tb12920.x","volume":"82","author":"Blum W. F.","year":"1993","journal-title":"Acta Paediatr."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1159\/000181581"},{"key":"B3","first-page":"770","volume":"80","author":"Bright G. M.","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.2.4594"},{"key":"B5","first-page":"423","volume":"17","author":"Feld S.","year":"1996","journal-title":"Endocr. Rev."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.130"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707163170303"},{"key":"B8","first-page":"115","volume":"97","author":"Higaki K.","year":"1997","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117427"},{"key":"B10","first-page":"3","volume":"16","author":"Jones J. I.","year":"1995","journal-title":"Endocr. Rev."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.17.310"},{"key":"B12","first-page":"404","volume":"78","author":"Lieberman S. A.","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B13","first-page":"1464","volume":"75","author":"Martha P. M. J.","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B14","first-page":"869","volume":"80","author":"Mauras N.","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/BF00866769"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.4.4727"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.164"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-219-44310"},{"key":"B19","first-page":"273","volume":"77","author":"Vaccarekkim M. A.","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.1999.277.4.E579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T17:20:35Z","timestamp":1567963235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.1999.277.4.E579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,10,1]]}},"alternative-id":["10.1152\/ajpendo.1999.277.4.E579"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.1999.277.4.e579","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10,1]]}}}